Cargando…
Metronomic chemotherapy prevents therapy-induced stromal activation and induction of tumor-initiating cells
Although traditional chemotherapy kills a fraction of tumor cells, it also activates the stroma and can promote the growth and survival of residual cancer cells to foster tumor recurrence and metastasis. Accordingly, overcoming the host response induced by chemotherapy could substantially improve th...
Autores principales: | Chan, Tze-Sian, Hsu, Chung-Chi, Pai, Vincent C., Liao, Wen-Ying, Huang, Shenq-Shyang, Tan, Kok-Tong, Yen, Chia-Jui, Hsu, Shu-Ching, Chen, Wei-Yu, Shan, Yan-Shen, Li, Chi-Rong, Lee, Michael T., Jiang, Kuan-Ying, Chu, Jui-Mei, Lien, Gi-Shih, Weaver, Valerie M., Tsai, Kelvin K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5154935/ https://www.ncbi.nlm.nih.gov/pubmed/27881732 http://dx.doi.org/10.1084/jem.20151665 |
Ejemplares similares
-
Correction: Metronomic chemotherapy prevents therapy-induced stromal activation and induction of tumor-initiating cells
por: Chan, Tze-Sian, et al.
Publicado: (2023) -
A Novel Invadopodia-Specific Marker for Invasive and Pro-Metastatic Cancer Stem Cells
por: Huang, Shenq-Shyang, et al.
Publicado: (2021) -
Corrigendum: A Novel Invadopodia-Specific Marker for Invasive and Pro-Metastatic Cancer Stem Cells
por: Huang, Shenq-Shyang, et al.
Publicado: (2021) -
Dishevelled 1-Regulated Superpotent Cancer Stem Cells Mediate Wnt Heterogeneity and Tumor Progression in Hepatocellular Carcinoma
por: Liao, Wen-Ying, et al.
Publicado: (2020) -
Breast cancer patient-derived organoid screening implicates the repressor NCOR2 in cytotoxic stress response and anti-tumor immunity
por: Tsai, Kelvin K., et al.
Publicado: (2022)